Specifically, it has been demonstrated that IL-1β could upregulate many proinflammatory genes, including IL-6, IL-17 and IFN-γ, resulting in further tissue injury and inflammation related events, like hypertension and myocardial infarction (99–101). The gene discussed is IL17A; the disease is hypertensive disorder.